BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35925236)

  • 1. [Update on the treatment of chronic prurigo].
    Zeidler C; Pereira MP; Ständer S
    Dermatologie (Heidelb); 2022 Aug; 73(8):614-619. PubMed ID: 35925236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic prurigo].
    Pereira MP; Nau T; Zeidler C; Ständer S
    Hautarzt; 2018 Apr; 69(4):321-330. PubMed ID: 29568995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prurigo Nodularis Management.
    Tsianakas A; Zeidler C; Ständer S
    Curr Probl Dermatol; 2016; 50():94-101. PubMed ID: 27578077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments.
    Müller S; Zeidler C; Ständer S
    Am J Clin Dermatol; 2024 Jan; 25(1):15-33. PubMed ID: 37717255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Prurigo.
    Thünemann J; Müller S; Steinbrink K; Ständer S; Zeidler C
    J Dtsch Dermatol Ges; 2024 Jun; 22(6):813-823. PubMed ID: 38722190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of biologics in prurigo nodularis.
    Müller S; Bieber T; Ständer S
    Expert Opin Biol Ther; 2022 Jan; 22(1):47-58. PubMed ID: 34289753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prurigo Nodularis and Its Management.
    Zeidler C; Yosipovitch G; Ständer S
    Dermatol Clin; 2018 Jul; 36(3):189-197. PubMed ID: 29929592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Prurigo of Nodular Type: A Review.
    Zeidler C; Tsianakas A; Pereira M; Ständer H; Yosipovitch G; Ständer S
    Acta Derm Venereol; 2018 Feb; 98(2):173-179. PubMed ID: 29135018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical evaluation of nemolizumab for prurigo nodularis.
    Brooks SG; Yosipovitch G
    Expert Rev Clin Immunol; 2024 Jun; 20(6):577-587. PubMed ID: 38217530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical review of dupilumab for adult patients with prurigo nodularis.
    Biazus Soares G; Yosipovitch G
    Expert Rev Clin Immunol; 2024 Mar; 20(3):249-254. PubMed ID: 37811660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic prurigo.
    Misery L
    Br J Dermatol; 2022 Oct; 187(4):464-471. PubMed ID: 35656799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
    Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
    N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prurigo: review of its pathogenesis, diagnosis, and treatment.
    Criado PR; Ianhez M; Criado RFJ; Nakano J; Lorenzini D; Miot HA
    An Bras Dermatol; 2024 Mar; ():. PubMed ID: 38493053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of 325 Patients with Chronic Nodular Prurigo: Clinics, Burden of Disease and Course of Treatment.
    Gründel S; Pereira MP; Storck M; Osada N; Schneider G; Ständer S; Zeidler C
    Acta Derm Venereol; 2020 Sep; 100(16):adv00269. PubMed ID: 32556359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INDIVIDUAL ARTICLE: Management of Prurigo Nodularis.
    Elmariah SB; Tao L; Valdes-Rodriguez R; Laquer V
    J Drugs Dermatol; 2023 Dec; 22(12):SF365502s15-SF365502s22. PubMed ID: 38051855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy for chronic pruritus-light at the end of a long tunnel?].
    Pereira MP; Salzmann S; Ständer S; Staubach P; Metz M
    Internist (Berl); 2020 Oct; 61(10):1076-1086. PubMed ID: 32676722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Pruritus: Current and Emerging Treatment Options.
    Pereira MP; Ständer S
    Drugs; 2017 Jun; 77(9):999-1007. PubMed ID: 28466423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Position Statement: Linear prurigo is a subtype of chronic prurigo.
    Pereira MP; Zeidler C; Nau T; Bobko S; Evers AWM; Garcovich S; Gonçalo M; Halvorsen JA; Lambert J; Legat FJ; Leslie T; Metz M; Misery L; Nordlind K; Reich A; Schneider G; Ständer H; Streit M; Szepietowski JC; Wallengren J; Weisshaar E; Ständer S;
    J Eur Acad Dermatol Venereol; 2019 Feb; 33(2):263-266. PubMed ID: 30288812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Atopic Chronic Nodular Prurigo (Prurigo Nodularis Hyde): A Systematic Review of Best-Evidenced Treatment Options.
    Frølunde AS; Wiis MAK; Ben Abdallah H; Elsgaard S; Danielsen AK; Deleuran M; Vestergaard C
    Dermatology; 2022; 238(5):950-960. PubMed ID: 35417906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of dupilumab in prurigo nodularis in elderly patient.
    Giura MT; Viola R; Fierro MT; Ribero S; Ortoncelli M
    Dermatol Ther; 2020 Jan; 33(1):e13201. PubMed ID: 31856368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.